Mouse research: a new approach to reverse recent-onset type 1 diabetes?
WebMD reports that research performed on mice shows promise in creating an approach that reverses recent-onset type 1 diabetes. Researchers from the La Jolla Institute for Allergy & Immunology (LIAI) used a combination therapy of systemic anti-CD3 antibody and intranasal proinsulin peptide. The team hopes to begin testing the combination therapy in human clinical trials later this year.